Skip to content

O'ACTIVE: what changed

Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

O'ACTIVE

BE 0886.735.396
NACE 46.460, Wholesale of pharmaceutical and medical goods
fiscal year 2024 against 2025filed annual accounts (NBB)
Net result for the year
-€12,053
2024 · €1,568-€13,621
Equity
€32,443
2024 · €44,496-€12,053
Cash
€1,395
2024 · €4,636-€3,241
Balance sheet total
€60,121
2024 · €69,943-€9,822

Largest movements

2024 to 2025
Assets
  • Stocks and contracts -€8,408

    down €8,408 (-17.9%), from €47,096 to €38,688

  • Receivables within one year +€7,494

    up €7,494 (+134.1%), from €5,588 to €13,082

  • Deferred charges and accrued income -€5,242

    down €5,242 (-44.4%), from €11,798 to €6,556

  • Cash -€3,241

    down €3,241 (-69.9%), from €4,636 to €1,395

    mainly Net result for the year (-€12,053) and Receivables within one year (-€7,494)

Equity and liabilities
  • Profit (loss) carried forward -€12,053

    down €12,053 (-74.6%), from €16,152 to €4,099

  • Trade debts +€7,245

    up €7,245 (+161.1%), from €4,497 to €11,742

  • Other debts -€4,335

    down €4,335 (-22.3%), from €19,413 to €15,078

  • Contributions -€1,860

    down €1,860 (-11.8%), from €15,760 to €13,900

  • Reserves +€1,860

    up €1,860 (+14.8%), from €12,584 to €14,444

Income statement
  • Gross operating margin -€7,327

    down €7,327, from €335 to -€6,992

  • Write-downs +€5,265

    no longer reported in 2025 (was -€5,265)

  • Other operating charges +€1,848

    up €1,848 (+269.4%), from €686 to €2,534

  • Financial charges -€551

    down €551 (-22.1%), from €2,494 to €1,943

  • Taxes -€155

    down €155 (-47.3%), from €328 to €173

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €1,568
Gross operating margin -€7,327
Depreciation +€98
Write-downs -€5,265
Other operating charges -€1,848
Financial income +€15
Financial charges +€551
Taxes +€155
Result 2025 -€12,053

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations -€3,240
Investment -€1
Financing €0
Cash 2024 €4,636
Net result for the year -€12,053
Depreciation +€426
Stocks and contracts +€8,408
Receivables within one year -€7,494
Deferred charges and accrued income +€5,242
Trade debts +€7,245
Tax, wage and social debts -€679
Other debts -€4,335
Investment in fixed assets (net) -€1
Cash 2025 €1,395
Every line side by side 38 lines
Line Code 2024 2025 Change %
Total assets 20/58 €69,943 €60,121 -€9,822 -14.0%
Fixed assets 21/28 €825 €400 -€425 -51.5%
Tangible fixed assets 22/27 €425 - -€425
Furniture and vehicles 24 €425 - -€425
Financial fixed assets 28 €400 €400 = 0.0%
Current assets 29/58 €69,118 €59,721 -€9,397 -13.6%
Stocks and contracts in progress 3 €47,096 €38,688 -€8,408 -17.9%
Stocks 30/36 €47,096 €38,688 -€8,408 -17.9%
Amounts receivable within one year 40/41 €5,588 €13,082 +€7,494 +134.1%
Trade receivables 40 €5,588 €13,082 +€7,494 +134.1%
Cash at bank and in hand 54/58 €4,636 €1,395 -€3,241 -69.9%
Deferred charges and accrued income 490/1 €11,798 €6,556 -€5,242 -44.4%
Total equity and liabilities 10/49 €69,943 €60,121 -€9,822 -14.0%
Equity 10/15 €44,496 €32,443 -€12,053 -27.1%
Contributions 10/11 €15,760 €13,900 -€1,860 -11.8%
Reserves 13 €12,584 €14,444 +€1,860 +14.8%
Distributable reserves 133 €12,584 €14,444 +€1,860 +14.8%
Profit (loss) carried forward 14 €16,152 €4,099 -€12,053 -74.6%
Amounts payable 17/49 €25,447 €27,678 +€2,231 +8.8%
Amounts payable within one year 42/48 €25,447 €27,678 +€2,231 +8.8%
Trade debts 44 €4,497 €11,742 +€7,245 +161.1%
Suppliers 440/4 €4,497 €11,742 +€7,245 +161.1%
Taxes, remuneration and social security 45 €1,537 €858 -€679 -44.2%
Taxes 450/3 €1,537 €858 -€679 -44.2%
Other amounts payable 47/48 €19,413 €15,078 -€4,335 -22.3%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €524 €426 -€98 -18.7%
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) 631/4 -€5,265 - +€5,265
Other operating charges 640/8 €686 €2,534 +€1,848 +269.4%
Gross operating margin 9900 €335 -€6,992 -€7,327
Operating profit (loss) 9901 €4,390 -€9,952 -€14,342
Financial income 75/76B - €15 +€15
Recurring financial income 75 - €15 +€15
Financial charges 65/66B €2,494 €1,943 -€551 -22.1%
Recurring financial charges 65 €2,494 €1,943 -€551 -22.1%
Profit (loss) for the period before taxes 9903 €1,896 -€11,880 -€13,776
Income taxes 67/77 €328 €173 -€155 -47.3%
Profit (loss) for the period 9904 €1,568 -€12,053 -€13,621
Profit (loss) for the period to be appropriated 9905 €1,568 -€12,053 -€13,621

Source: filed annual accounts (NBB), fiscal years ended 30 June 2024 and 30 June 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 6 October 2026 via checked.be.